Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
30958 | 160 | 25.6 | 42% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
658 | 3 | COENZYME Q10//UBIQUINONE//COENZYME Q | 11100 |
2774 | 2 | VINPOCETINE//NEFIRACETAM//PIRACETAM | 3137 |
30958 | 1 | NICERGOLINE//SERMION//CAS 27848 84 6 | 160 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NICERGOLINE | authKW | 2431820 | 18% | 44% | 29 |
2 | SERMION | authKW | 429404 | 2% | 75% | 3 |
3 | CAS 27848 84 6 | authKW | 254461 | 1% | 67% | 2 |
4 | MARKET CO ITALY | address | 254461 | 1% | 67% | 2 |
5 | SANDOZ CLINICAL ASSESSMENT GERIATRIC SCALE | authKW | 254461 | 1% | 67% | 2 |
6 | 17 C 14 NICERGOLINE | authKW | 190847 | 1% | 100% | 1 |
7 | 2 METHYL 6 P METHOXYPHENYL 3 7DIHYDROIMIDAZO1 2 APYRAZIN 3 ONE DEPENDENT CHEMILUMINESCENT METHOD | authKW | 190847 | 1% | 100% | 1 |
8 | 4 ACETYL 4 PHENYLPIPERIDINE | authKW | 190847 | 1% | 100% | 1 |
9 | 4 HYDROXY 4 PHENYLPIPERIDINE | authKW | 190847 | 1% | 100% | 1 |
10 | 5 HT2B AGONISM | authKW | 190847 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 996 | 46% | 0% | 74 |
2 | Geriatrics & Gerontology | 293 | 8% | 0% | 12 |
3 | Psychiatry | 101 | 10% | 0% | 16 |
4 | Chemistry, Medicinal | 85 | 8% | 0% | 12 |
5 | Cardiac & Cardiovascular System | 70 | 9% | 0% | 15 |
6 | Neurosciences | 37 | 11% | 0% | 18 |
7 | Clinical Neurology | 30 | 8% | 0% | 12 |
8 | Crystallography | 13 | 3% | 0% | 5 |
9 | Peripheral Vascular Diseases | 10 | 3% | 0% | 5 |
10 | Chemistry, Multidisciplinary | 7 | 8% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MARKET CO ITALY | 254461 | 1% | 67% | 2 |
2 | CNS MED DEV | 190847 | 1% | 100% | 1 |
3 | MARKET CO ITALY MED | 190847 | 1% | 100% | 1 |
4 | MARKET CORP ITALY | 190847 | 1% | 100% | 1 |
5 | NEUROL C MONDINO IRCCS | 190847 | 1% | 100% | 1 |
6 | NEUROL IRCCS SANTA LUCIA | 190847 | 1% | 100% | 1 |
7 | BRAIN FUNCT INC | 95422 | 1% | 50% | 1 |
8 | PHARMACEUT MARKETING HEADQUARTERS | 95422 | 1% | 50% | 1 |
9 | COMMON USE IL MED | 63614 | 1% | 33% | 1 |
10 | GERBERA | 23854 | 1% | 13% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL DE PHARMACOLOGIE | 27901 | 4% | 2% | 7 |
2 | REVISTA BRASILEIRA DE MEDICINA | 7786 | 1% | 2% | 2 |
3 | RESEARCH COMMUNICATIONS IN PSYCHOLOGY PSYCHIATRY AND BEHAVIOR | 2921 | 1% | 1% | 2 |
4 | FOLIA PHARMACOLOGICA JAPONICA | 2773 | 3% | 0% | 4 |
5 | METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2631 | 4% | 0% | 6 |
6 | DEMENTIA AND GERIATRIC COGNITIVE DISORDERS | 2540 | 3% | 0% | 5 |
7 | ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE | 2094 | 3% | 0% | 4 |
8 | MEDECINE & CHIRURGIE DIGESTIVES | 1851 | 1% | 1% | 1 |
9 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1556 | 4% | 0% | 6 |
10 | CLINICAL DRUG INVESTIGATION | 1393 | 3% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WINBLAD, B , FIORAVANTI, M , DOLEZAL, T , LOGINA, I , MILANOV, IG , POPESCUB, DC , SOLOMON, A , (2008) THERAPEUTIC USE OF NICERGOLINE.CLINICAL DRUG INVESTIGATION. VOL. 28. ISSUE 9. P. 533-552 | 35 | 60% | 20 |
2 | SALETU, B , GARG, A , SHOEB, A , (2014) SAFETY OF NICERGOLINE AS AN AGENT FOR MANAGEMENT OF COGNITIVE FUNCTION DISORDERS.BIOMED RESEARCH INTERNATIONAL. VOL. . ISSUE . P. - | 23 | 66% | 0 |
3 | FIORAVANTI, M , NAKASHIMA, T , XU, J , GARG, A , (2014) A SYSTEMATIC REVIEW AND META-ANALYSIS ASSESSING ADVERSE EVENT PROFILE AND TOLERABILITY OF NICERGOLINE.BMJ OPEN. VOL. 4. ISSUE 7. P. - | 15 | 54% | 2 |
4 | DAMULIN, IV , (2010) THERAPEUTIC POTENTIAL AND POSSIBILITIES OF USING OF SERMION (NICERGOLINE) IN NEUROLOGICAL PRACTICE.ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA. VOL. 110. ISSUE 12. P. 119 -122 | 11 | 79% | 0 |
5 | WINBLAD, B , CARFAGNA, N , BONURA, L , ROSSINI, BM , WONG, EHF , BATTAGLIA, A , (2000) NICERGOLINE IN DEMENTIA - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL.CNS DRUGS. VOL. 14. ISSUE 4. P. 267 -287 | 20 | 35% | 6 |
6 | EZAN, E , DELESTRE, L , LEGENDRE, S , RIVIERE, R , DOIGNON, JL , GROGNET, JM , (2001) IMMUNOASSAYS FOR THE DETECTION OF NICERGOLINE AND ITS METABOLITES IN HUMAN PLASMA.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 25. ISSUE 1. P. 123-130 | 9 | 69% | 5 |
7 | CARACI, F , CHISARI, M , FRASCA, G , CANONICO, PL , BATTAGLIA, A , CALAFIORE, M , BATTAGLIA, G , BOSCO, P , NICOLETTI, F , COPANI, A , ET AL (2005) NICERGOLINE, A DRUG USED FOR AGE-DEPENDENT COGNITIVE IMPAIRMENT, PROTECTS CULTURED NEURONS AGAINST BETA-AMYLOID TOXICITY.BRAIN RESEARCH. VOL. 1047. ISSUE 1. P. 30 -37 | 13 | 38% | 14 |
8 | NISHIDA, A , IWATA, H , KUDO, Y , KOBAYASHI, T , MATSUOKA, Y , KANAI, Y , ENDOU, H , (2004) NICERGOLINE ENHANCES GLUTAMATE UPTAKE VIA GLUTAMATE TRANSPORTERS IN RAT CORTICAL SYNAPTOSOMES.BIOLOGICAL & PHARMACEUTICAL BULLETIN. VOL. 27. ISSUE 6. P. 817 -820 | 13 | 39% | 7 |
9 | CEJKA, J , KRATOCHVIL, B , CVAK, L , JEGOROV, A , (2005) CRYSTAL STRUCTURE OF 1-METHYL-10 ALPHA-METHOXY-9,10-DIHYDROLYSERGOL, C18H24N2O2.ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES. VOL. 220. ISSUE 2. P. 207-208 | 5 | 100% | 0 |
10 | CEJKA, J , KRATOCHVIL, B , CVAK, L , JEGOROV, A , (2005) CRYSTAL STRUCTURE OF 1-HYDROXYMETHYL-10 ALPHA-METHOXY-9,10-DIHYDROLYSERGOL, C18H24N2O3.ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES. VOL. 220. ISSUE 3. P. 351-352 | 4 | 100% | 0 |
Classes with closest relation at Level 1 |